General Information of Drug (ID:
DR0779) |
Drug Name |
Gliquidone
|
Synonyms |
Gliquidona; Gliquidona [INN-Spanish]; Gliquidone; Gliquidonum; Gliquidonum [INN-Latin]; Glurenorm; glikvidon; glycvidon; Beglynor; Beglynora; 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea; 33342-05-1; BRN 1559726; C27H33N3O6S; C7C2QDD75P; CAS-33342-05-1; DSSTox_CID_3096; DSSTox_GSID_23096; DSSTox_RID_76873; EINECS 251-463-2; MFCD00631870; NCGC00016819-01; ARDF 26; ARDF 26 SE; UNII-C7C2QDD75P
|
Indication |
Diabetes mellitus
[ICD11: 5A10]
|
Phase 4
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
527.6 |
Topological Polar Surface Area |
130 |
Heavy Atom Count |
37 |
Rotatable Bond Count |
7 |
Hydrogen Bond Donor Count |
2 |
Hydrogen Bond Acceptor Count |
6 |
Cross-matching ID |
- PubChem CID
- 91610
- PubChem SID
-
7449309
; 7849488
; 7979418
; 10224909
; 11112731
; 11467019
; 11468139
; 11486708
; 14860897
; 44422540
; 46508425
; 47381693
; 47381694
; 47604985
; 47901629
; 48351264
; 48416055
; 49699236
; 49832468
; 49881412
; 50060569
; 50085433
; 50124024
; 50796154
; 56463591
; 57334969
; 81041002
; 81065941
; 81092899
; 85787540
; 87560715
; 92125987
; 92717029
; 103481945
; 103914607
; 104405238
; 105585086
; 121363658
; 124882576
; 124882577
; 125204729
; 125348208
; 126622557
; 126654118
; 126739661
; 128505786
; 131310850
; 134338200
; 135049036
; 137005778
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D06HBQ
- Formula
- C27H33N3O6S
- Canonical SMILES
- CC1(C2=C(C=C(C=C2)OC)C(=O)N(C1=O)CCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C
- InChI
- 1S/C27H33N3O6S/c1-27(2)23-14-11-20(36-3)17-22(23)24(31)30(25(27)32)16-15-18-9-12-21(13-10-18)37(34,35)29-26(33)28-19-7-5-4-6-8-19/h9-14,17,19H,4-8,15-16H2,1-3H3,(H2,28,29,33)
- InChIKey
- LLJFMFZYVVLQKT-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.